Global Comparison & International Data

Germany maintains a nationwide network of Borrelia reference laboratories with standardized two-tier testing (ELISA + immunoblot). The National Reference Centre for Borrelia at the Bavarian Health Authority provides confirmatory testing, strain characterization, and epidemiological surveillance. Tick-borne disease is a reportable condition in five eastern states, enabling granular incidence tracking.

Following the landmark 2021 NICE guideline revision (NG206), the UK reversed its longstanding recommendation of graded exercise therapy for ME/CFS. The NHS now funds specialist multidisciplinary clinics providing pacing-based management, occupational therapy, and symptom-specific pharmacology. Over 30 dedicated ME/CFS clinics now operate across England, Scotland, and Wales.

The 2016 Senate inquiry into the growing evidence of an Australian Lyme-like illness led to the establishment of the Australian Lyme Disease Advisory Committee (ALDAC). The government funded the CSIRO Lyme-like illness research program, investigating novel Borrelia species and tick-borne pathogens endemic to Australia, validating patient experiences previously dismissed.

Sweden pioneered dedicated fatigue research and treatment centers, including the Gottfries Clinic and the Karolinska Institutet ME/CFS program. These centers combine clinical care with active research programs, studying biomarkers (cytokine panels, metabolomics), neuroimaging findings, and therapeutic interventions including low-dose naltrexone and rituximab trials.